The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours ...

Chinese clinical scientist Wang Yongjun has been granted the William M. Feinberg Award for Excellence in Clinical Stroke at the 2025 International ...

Injecting tenecteplase into the artery after clot removal helps improve recovery in stroke survivors by enhancing blood flow ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery ...

In a randomized clinical trial in China, giving the clot-busting medication alteplase up to 24 hours after stroke symptoms ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days ...

Mechanically retrieving a blood clot blocking a medium- or small-sized brain artery was no better at reducing disability 90 ...

Stroke experts from UCSF Health presented new research and clinical findings at the annual the American Stroke Association’s International Stroke Conference (ISC25), the world’s premier meeting ...

Eleven scientists will be recognized for their individual exceptional professional achievements and contributions to stroke care and research during the American Stroke Association’s International ...

Addressing the conference, Wang said that over the past 30 years, his team of clinical scientists has produced 12 key pieces of evidence that have changed clinical guidelines and clinical practice.

Mechanically retrieving a blood clot blocking a medium- or small-sized brain artery was no better at reducing disability 90 ...